Investor Presentation First Nine Months of 2023

139 Investor presentation First nine months of 2023 Insulin market size and volume market share in North America Operations Total Insulin market share and market size (DKK billion) Long- acting 37% 42% Fast- 51% 79 acting 59% Premix 7 Human 24% 16 105 Novo Nordisk Competitors NAO Market growth1 A Market share Insulin volume: Market share 60% 12% 206 -1.7% -0.1% -3.1% +0.1% 40% 8% 38% 4% 0% 1.1% -0.4% 20% -4% -4% -12.2% +0.9% 0% Aug 2020 -1.1% -0.6% -5% -8% Aug 2023 NN market share -Market growth (right axis) ―NN growth (right axis) 1Market growth is YTD current vs YTD previous year Note: Insulin market numbers do not reflect rebates. Source: IQVIA, Aug 2023, LHS graph - Value, RHS Graph - Volume, MAT, all countries. Share of growth not depicted due to too high numbers; NN: Novo Nordisk; Market values are based on the list prices

View entire presentation